Log in

Company updateMoneycontrol

Wockhardt plans US Zaynich launch via publications

Positive+39

GreyOak summary

The company chose to market the drug directly rather than out-license it.

What it affects

  • Preparing US launch with scientific publications.Rolling sentiment Positive +15

Source

Read the original at Moneycontrol

More Wockhardt news

No other recent stories about Wockhardt.

All Wockhardt news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy